The trademark application Evartia was filed by MEDICOVER BIOTECH LTD, a corporation established under the laws of the Republic of Cyprus (the "Applicant"). The application was published for oppositions on June 29, 2021, and it was registered by office on October 6, 2021 without any oppositions.
The application was filed in English (French was selected as the second language).
Appointment and Replacement of representative of the trademark registration was recorded on April 19, 2022. Appointment and Replacement of representative of the trademark registration was recorded on July 17, 2022. Change of name and address of the trademark registration was recorded on September 14, 2022. Appointment and Replacement of representative of the trademark registration was recorded on November 16, 2023.
Goods And Services
The mark was filed in class 1 with following description of goods:
Kits composed of reagents for genetic testing for medical and scientific research purposes
Kits composed of reagents for genetic testing for medical and scientific research purposes in the field of metabolic diseases
Kits composed of reagents for metabolic genetic testing for medical and scientific research purposes
Nucleic acid-based kits and reagents for testing metabolic diseases for medical and scientific research purposes.
The mark was filed in class 42 with following description of goods:
Medical laboratory services for metabolic genetic tests
Medical laboratory services for identifying genetic mutations in development of metabolic diseases
Design and development of medical diagnostic tests and products
Medical and scientific research in the field of genetic testing
Providing medical and scientific research information in the field of genetic testing
Genetic testing for scientific research and analysis purposes in the field of metabolic genetics
Genetic engineering services
Scientific, laboratory, clinical, medical, and technological research and analysis services in the fields of nucleic acid analysis, metabolic testing, and genetics
Scientific research for medical purposes in the area of metabolic diseases.
The mark was filed in class 44 with following description of goods:
Medical analysis services for the diagnosis and prognosis of metabolic diseases
Medical genetic testing services for diagnosis, prevention and treatment of metabolic diseases
Medical testing of biological samples for diagnosis of metabolic diseases
Genetic testing and genetic counseling in the field of metabolic diseases
Medical and health services relating to DNA and genetics testing
RNA or DNA analysis for metabolic disease diagnosis and prognosis.